Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: J Pharmacol Exp Ther. 1999 Dec;291(3):1113–1120.

TABLE 3.

Magnitude of rightward shift for dose-effect curves of U50,488 and bremazocine in antinociception after nor-BNI pretreatment

Dose Ratiosa

Days after
nor-BNI
i.c. nor-BNI 0.32 mg i.c. nor-BNI 0.032 mg s.c. nor-BNI 0.32 mg



versus
U50,488
versus
bremazocine
versus
U50,488
versus
bremazocine
versus
U50,488
versus
bremazocine
1 9.5* 3.0* 1.0
3 1.8 0.9 1.0
7 7.5* 2.5* 1.2
10 1.9 0.8 1.0
14 3.9* 1.0
21 7.9* 0.8
28 2.0 1.0
35 5.4* 0.7
42 0.7
49 1.5
56 1.0
63 1.0
a

Dose ratios were mean of individual dose ratio values (n = 4).

*

Significant rightward shift of dose-effect curve *p < .05.